BIOCEPT INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Biocept Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2023.
  • Biocept Inc Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2023 was $8.19M, a 6.49% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $8.19M -$568K -6.49% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $8.34M -$553K -6.22% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $8.49M -$540K -5.98% Dec 31, 2022 10-Q 2023-08-14
Q3 2022 $8.62M -$526K -5.75% Sep 30, 2022 10-Q/A 2023-04-17
Q2 2022 $8.76M -$517K -5.58% Jun 30, 2022 10-Q 2022-11-10
Q1 2022 $8.89M -$515K -5.48% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 $9.03M -$750K -7.67% Dec 31, 2021 10-K 2023-04-17
Q3 2021 $9.15M +$8.91M +3788% Sep 30, 2021 10-Q/A 2022-02-15
Q2 2021 $9.28M +$8.69M +1478% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $9.41M +$8.99M +2143% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $9.78M +$9.05M +1240% Dec 31, 2020 10-K 2022-04-05
Q3 2020 $235K -$800K -77.3% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $588K -$749K -56% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $419K -$1.22M -74.4% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $729K Dec 31, 2019 10-K 2021-03-31
Q3 2019 $1.04M Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $1.34M Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $1.64M Mar 31, 2019 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.